Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation

Xiaoyan He,1 Huijuan Ma2 1Special Medical Department, Beijing Jiangong Hospital, Beijing 100054, People’s Republic of China; 2Department of Endocrinology, Hebei General Hospital, Shijiazhuang 050051, People’s Republic of ChinaCorrespondence: Xiaoyan HeSpecial Medical Department,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	He X, Ma H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	secreted frizzled-related protein 5 type 2 diabetes mellitus obesity insulin resistance metformin Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/c45d7b2e75de498ba4bcf558e854b524
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c45d7b2e75de498ba4bcf558e854b524
record_format	dspace
spelling	oai:doaj.org-article:c45d7b2e75de498ba4bcf558e854b5242021-12-02T09:00:52ZCorrelation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation1178-7007https://doaj.org/article/c45d7b2e75de498ba4bcf558e854b5242020-04-01T00:00:00Zhttps://www.dovepress.com/correlation-between-circulating-levels-of-secreted-frizzled-related-pr-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Xiaoyan He,1 Huijuan Ma2 1Special Medical Department, Beijing Jiangong Hospital, Beijing 100054, People’s Republic of China; 2Department of Endocrinology, Hebei General Hospital, Shijiazhuang 050051, People’s Republic of ChinaCorrespondence: Xiaoyan HeSpecial Medical Department, Beijing Jiangong Hospital, Beijing 100054, People’s Republic of ChinaEmail nongxteeng@zoho.com.cnBackground: Secreted frizzled-related protein 5 (SFRP5) is a recently identified adipokine; however, its functions during pathogenesis of T2DM and obesity remain unclear. This research attempted to investigate associations between circulating SFRP5 and obesity/T2DM.Materials and Methods: According to diagnosis, 107 patients were assigned as impaired-glucose regulation (IGR) and 111 patients newly-diagnosed as T2DM were assigned as the T2DM group. Meanwhile, 132 subjects with normal-glucose tolerance (NGT) were assigned as the NGT group. Differences in plasma SFRP5 levels among three groups were compared. Correlation between SFRP5 levels and different metabolic markers was analyzed. Multiple-linear stepwise regression analyses were performed to determine independent factors for SFRP5. Patients in the T2DM group were administrated with metformin for 12 weeks. Meanwhile, changes in plasma SFRP5 levels were also analyzed.Results: Plasma SFRP5 level of the IGR group was significantly lower compared to the NGT group (219.1± 39.7 pg/mL vs 236.7± 72.6 pg/mL, P< 0.05), however, that of the T2DM group was significantly lower compared to the IGR group (203.5± 42.1 pg/mL vs 219.1± 39.7 pg/mL, P< 0.01). Level of plasma SFRP5 was negatively correlated with fasting plasma glucose, BMI, waist circumference (WC), normalized WC (waist-to-height ratio) (WHtR), 2h plasma glucose, fasting insulin, glycosylated hemoglobin (HbA1c), fasting C-peptide, HOMA-IR, and hs-CRP (P< 0.01). Among the above factors, HbA1c and fasting insulin levels (FIns) were two independent factors. Plasma SFRP5 levels were increased after 12-week metformin treatment (201.0± 34.8 pg/mL vs 213.1± 34.4 pg/mL, P< 0.05), while insulin resistance was alleviated (ln(HOMA-IR): 1.35± 0.55 vs 1.07± 0.49, P< 0.01).Conclusion: Metformin reduced circulating levels of secreted frizzled-related protein 5 and improved pathophysiological parameters of T2DM.Keywords: secreted frizzled-related protein 5, type 2 diabetes mellitus, obesity, insulin resistance, metforminHe XMa HDove Medical Pressarticlesecreted frizzled-related protein 5type 2 diabetes mellitusobesityinsulin resistancemetforminSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 13, Pp 1243-1250 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	secreted frizzled-related protein 5 type 2 diabetes mellitus obesity insulin resistance metformin Specialties of internal medicine RC581-951
spellingShingle	secreted frizzled-related protein 5 type 2 diabetes mellitus obesity insulin resistance metformin Specialties of internal medicine RC581-951 He X Ma H Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation
description	Xiaoyan He,1 Huijuan Ma2 1Special Medical Department, Beijing Jiangong Hospital, Beijing 100054, People’s Republic of China; 2Department of Endocrinology, Hebei General Hospital, Shijiazhuang 050051, People’s Republic of ChinaCorrespondence: Xiaoyan HeSpecial Medical Department, Beijing Jiangong Hospital, Beijing 100054, People’s Republic of ChinaEmail nongxteeng@zoho.com.cnBackground: Secreted frizzled-related protein 5 (SFRP5) is a recently identified adipokine; however, its functions during pathogenesis of T2DM and obesity remain unclear. This research attempted to investigate associations between circulating SFRP5 and obesity/T2DM.Materials and Methods: According to diagnosis, 107 patients were assigned as impaired-glucose regulation (IGR) and 111 patients newly-diagnosed as T2DM were assigned as the T2DM group. Meanwhile, 132 subjects with normal-glucose tolerance (NGT) were assigned as the NGT group. Differences in plasma SFRP5 levels among three groups were compared. Correlation between SFRP5 levels and different metabolic markers was analyzed. Multiple-linear stepwise regression analyses were performed to determine independent factors for SFRP5. Patients in the T2DM group were administrated with metformin for 12 weeks. Meanwhile, changes in plasma SFRP5 levels were also analyzed.Results: Plasma SFRP5 level of the IGR group was significantly lower compared to the NGT group (219.1± 39.7 pg/mL vs 236.7± 72.6 pg/mL, P< 0.05), however, that of the T2DM group was significantly lower compared to the IGR group (203.5± 42.1 pg/mL vs 219.1± 39.7 pg/mL, P< 0.01). Level of plasma SFRP5 was negatively correlated with fasting plasma glucose, BMI, waist circumference (WC), normalized WC (waist-to-height ratio) (WHtR), 2h plasma glucose, fasting insulin, glycosylated hemoglobin (HbA1c), fasting C-peptide, HOMA-IR, and hs-CRP (P< 0.01). Among the above factors, HbA1c and fasting insulin levels (FIns) were two independent factors. Plasma SFRP5 levels were increased after 12-week metformin treatment (201.0± 34.8 pg/mL vs 213.1± 34.4 pg/mL, P< 0.05), while insulin resistance was alleviated (ln(HOMA-IR): 1.35± 0.55 vs 1.07± 0.49, P< 0.01).Conclusion: Metformin reduced circulating levels of secreted frizzled-related protein 5 and improved pathophysiological parameters of T2DM.Keywords: secreted frizzled-related protein 5, type 2 diabetes mellitus, obesity, insulin resistance, metformin
format	article
author	He X Ma H
author_facet	He X Ma H
author_sort	He X
title	Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation
title_short	Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation
title_full	Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation
title_fullStr	Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation
title_full_unstemmed	Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation
title_sort	correlation between circulating levels of secreted frizzled-related protein 5 and type 2 diabetic patients and subjects with impaired-glucose regulation
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/c45d7b2e75de498ba4bcf558e854b524
work_keys_str_mv	AT hex correlationbetweencirculatinglevelsofsecretedfrizzledrelatedprotein5andtype2diabeticpatientsandsubjectswithimpairedglucoseregulation AT mah correlationbetweencirculatinglevelsofsecretedfrizzledrelatedprotein5andtype2diabeticpatientsandsubjectswithimpairedglucoseregulation
_version_	1718398270323032064

Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation

Ejemplares similares